173 related articles for article (PubMed ID: 9610915)
1. CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response.
Nieland JD; Graus YF; Dortmans YE; Kremers BL; Kruisbeek AM
J Immunother; 1998 May; 21(3):225-36. PubMed ID: 9610915
[TBL] [Abstract][Full Text] [Related]
2. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
Bullock TN; Yagita H
J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response.
Douin-Echinard V; Péron JM; Lauwers-Cancès V; Favre G; Couderc B
Int Immunol; 2003 Mar; 15(3):359-72. PubMed ID: 12618480
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs.
Taraban VY; Rowley TF; Al-Shamkhani A
J Immunol; 2004 Dec; 173(11):6542-6. PubMed ID: 15557144
[TBL] [Abstract][Full Text] [Related]
6. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
Nieland JD; Kruisbeek AM
Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
[TBL] [Abstract][Full Text] [Related]
7. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.
Schmitter D; Bolliger U; Hallek M; Pichert G
Br J Haematol; 1999 Jul; 106(1):64-70. PubMed ID: 10444164
[TBL] [Abstract][Full Text] [Related]
9. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
10. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
11. CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses.
Van Deusen KE; Rajapakse R; Bullock TN
J Leukoc Biol; 2010 Mar; 87(3):477-85. PubMed ID: 19952354
[TBL] [Abstract][Full Text] [Related]
12. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
13. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.
Kurche JS; Burchill MA; Sanchez PJ; Haluszczak C; Kedl RM
J Immunol; 2010 Aug; 185(4):2106-15. PubMed ID: 20639485
[TBL] [Abstract][Full Text] [Related]
14. T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity.
Lee SE; Shin AR; Sohn HJ; Cho HI; Kim TG
Cancer Res Treat; 2020 Jul; 52(3):747-763. PubMed ID: 32065848
[TBL] [Abstract][Full Text] [Related]
15. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
Yang G; Hellström KE; Hellström I; Chen L
J Immunol; 1995 Mar; 154(6):2794-800. PubMed ID: 7533183
[TBL] [Abstract][Full Text] [Related]
16. Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity.
McWilliams JA; Sanchez PJ; Haluszczak C; Gapin L; Kedl RM
Vaccine; 2010 Feb; 28(6):1468-76. PubMed ID: 19995538
[TBL] [Abstract][Full Text] [Related]
17. Characterization of murine CD70 by molecular cloning and mAb.
Oshima H; Nakano H; Nohara C; Kobata T; Nakajima A; Jenkins NA; Gilbert DJ; Copeland NG; Muto T; Yagita H; Okumura K
Int Immunol; 1998 Apr; 10(4):517-26. PubMed ID: 9620608
[TBL] [Abstract][Full Text] [Related]
18. Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation.
French RR; Taraban VY; Crowther GR; Rowley TF; Gray JC; Johnson PW; Tutt AL; Al-Shamkhani A; Glennie MJ
Blood; 2007 Jun; 109(11):4810-5. PubMed ID: 17311995
[TBL] [Abstract][Full Text] [Related]
19. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]